Insider Transactions in Q1 2022 at Phio Pharmaceuticals Corp. (PHIO)
Insider Transaction List (Q1 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 01
2022
|
Gerrit Dispersyn President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
8,954
-4.05%
|
$0
$0.82 P/Share
|
|
Mar 01
2022
|
Caitlin Kontulis Secretary & VP Finance & Admin |
SELL
Payment of exercise price or tax liability
|
Direct |
4,011
-3.72%
|
$0
$0.82 P/Share
|
|
Feb 15
2022
|
Robert J Bitterman Chairman, Pres & CEO |
BUY
Grant, award, or other acquisition
|
Direct |
10,000
+27.91%
|
-
|
|
Feb 15
2022
|
Geert Cauwenbergh Director |
BUY
Grant, award, or other acquisition
|
Direct |
10,000
+23.35%
|
-
|
|
Feb 15
2022
|
Gerrit Dispersyn President & CEO |
BUY
Grant, award, or other acquisition
|
Direct |
126,000
+36.28%
|
-
|
|
Feb 15
2022
|
H. Paul Dorman Director |
BUY
Grant, award, or other acquisition
|
Direct |
10,000
+32.93%
|
-
|
|
Feb 15
2022
|
Robert L Ferrara Director |
BUY
Grant, award, or other acquisition
|
Direct |
10,000
+30.3%
|
-
|
|
Feb 15
2022
|
Jonathan E Freeman Director |
BUY
Grant, award, or other acquisition
|
Direct |
10,000
+32.93%
|
-
|
|
Feb 15
2022
|
Caitlin Kontulis Secretary & VP Finance & Admin |
BUY
Grant, award, or other acquisition
|
Direct |
68,000
+38.67%
|
-
|
|
Feb 15
2022
|
Curtis Lockshin Director |
BUY
Grant, award, or other acquisition
|
Direct |
10,000
+32.93%
|
-
|